Aurora Cannabis Inc. announced the completion of a multi-year, $3 million investment in improvements to its manufacturing facility in Pemberton, British Columbia. These upgrades, integrating proprietary high-performing genetics and state-of-the-art engineering, have resulted in a doubling of yield and potency, reaching a record 33.7%.
The facility, formerly the Whistler Medical Marijuana Company site, has been renamed Aurora Alpine to reflect its enhanced potential and location. This GACP certified facility is now poised to expand Aurora's global reach by exporting premium medical cannabis internationally.
This investment underscores Aurora's commitment to operational excellence and advancing cultivation technologies. The improvements have not only increased manufacturing capabilities but also set new industry standards for efficiency and precision, solidifying Aurora's leadership in the cannabis industry.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.